Hinge Health, Inc. (NYSE: HNGE) reported Q2 EPS of $0.59, $0.46 better than the analyst estimate of $0.13. Revenue for the quarter came in at $212.82 million, versus $0 reported last year.

GUIDANCE:

Hinge Health, Inc. sees Q3 2026 revenue of $223-225 million, versus the consensus of $211.5 million.

Hinge Health, Inc. sees FY2026 revenue of $856-860 million, versus the consensus of $822.2 million.

For earnings history and earnings-related data on Hinge Health, Inc. (HNGE) click here.